Evaluation Of A Production Ready Portable, Point-of-need Platform (instrument And Reagents), Direct From Nasal Swab Test For The Molecular Diagnostic Detection Of Covid-19 Infection.

  Address - France

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10363898

  Document Type - Tender Notices

Description - Grant agreement ID: 101005075Start date 1 September 2020End date 31 December 2021Overall budget € 1 819 963,75 Objective This project focuses on rapid (40min), simple, Point-of-Need COVID-19 testing, e.g. surgery/home (via first responders)/transit points of entry. BG Research (BGR) has developed direct from crude sample detection of viral pathogens – the QuRapID-XF technology, removing requirement for nucleic acid extraction, expert users or a laboratory; results delivered while you wait. Tests utilise the Gold Standard polymerase chain technology as current clinical reference tests, but using our novel reagent, directly breaking open the virus and a single enzyme system that is resista

Mt Ref Id - 10363898

Deadline - Dec 31, 2024